GMP Cell Therapy Consumables Market Report Provides Insights Into Market Evolution And Growth Prospects

The GMP cell therapy consumables market is gaining remarkable traction as advancements in cell therapies continue to accelerate globally. This sector is set to experience substantial expansion, driven by rising demand for high-quality, compliant materials essential for the production and commercialization of innovative therapeutic products. Here is an in-depth view of the market size, key players, trends, and segmentation shaping this dynamic industry.

Projected Growth and Market Size of the GMP Cell Therapy Consumables Market
The GMP cell therapy consumables market is poised for extraordinary growth, with its value anticipated to reach $73.96 billion by 2030. This impressive expansion corresponds to a compound annual growth rate (CAGR) of 26.6%. Several factors underpin this surge, including the rapid commercialization of cell therapies, increasing need for scalable GMP production processes, and the broadening pipelines of gene and immunotherapies. Additionally, the emphasis on process automation and stricter regulatory oversight for cell therapy manufacturing are critical contributors to this growth. Prominent trends forecasted for the market include heightened demand for GMP-compliant consumables, widespread adoption of single-use bioprocessing technologies, increased use of automated cell processing systems, development of standardized cell culture solutions, and a reinforced focus on maintaining quality and regulatory compliance.

Download a free sample of the gmp cell therapy consumables market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Leaders in the GMP Cell Therapy Consumables Market
Key companies are shaping the future of the GMP cell therapy consumables market, including well-known names such as Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Sartorius AG, Corning Incorporated, Avantor Inc., Fresenius Kabi AG, Miltenyi Biotec, Bio-Techne Corp, STEMCELL Technologies Inc., FUJIFILM Irvine Scientific Inc., BioLife Solutions Inc., PromoCell GmbH, PeproTech Inc., Sino Biological Inc., Wilson Wolf Corporation, Cellexus Ltd., MaxCyte Inc., BioLegend Inc., Repligen Corporation, and Terumo Corporation.

A significant development occurred in March 2023 when Sartorius AG, a German provider specializing in bioprocess solutions and laboratory instruments, acquired Polyplus for about €2.4 billion (approximately US$2.6 billion). This strategic acquisition strengthens Sartorius's position as a top supplier of critical upstream technologies for cell and gene therapies. By incorporating Polyplus's transfection reagents and GMP-grade plasmid DNA into its existing portfolio of cell culture media and bioprocess components, Sartorius enhances its capabilities to support viral vector manufacturing workflows essential for advanced therapies. Polyplus, based in France, is known for producing high-quality transfection reagents, DNA/RNA delivery reagents, and GMP-grade plasmid DNA-vital inputs in the production of viral vectors for cell and gene therapies as well as other advanced medicinal products.

View the full gmp cell therapy consumables market report:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Driving Forces Behind the Growth of GMP Cell Therapy Consumables Market
A major factor fueling market expansion is the increasing commercialization of cell therapies, which demands a growing supply of GMP-compliant consumables. As more therapies advance through clinical trials to commercial availability, manufacturers require reliable and scalable production materials to meet quality and regulatory standards.

Another important driver is the rising adoption of automated and single-use technologies in cell processing. These innovations improve efficiency, reduce contamination risks, and support the scalability of manufacturing processes, thereby accelerating the overall growth of the GMP cell therapy consumables market.

Important Trends Shaping the GMP Cell Therapy Consumables Market
Companies in this market are focusing on the development of GMP-compliant CD34+ hematopoietic stem cells (HSCs), which are crucial for next-generation therapies targeting blood cancers and genetic diseases. These stem cells are characterized by the CD34 marker and are produced under strict GMP conditions to ensure safety and efficacy.

For example, in April 2024, OrganaBio, a US-based pharmaceutical firm, introduced HematoPAC-HSC-CB-GMP, an on-demand source of GMP-compliant CD34+ HSCs derived from fresh human cord blood. Leveraging its expertise in cell isolation and GMP manufacturing, OrganaBio is able to generate high yields of viable CD34+ HSCs within 24 hours of collection. This product launch supports the development of innovative therapies by providing a reliable supply of high-quality stem cells.

Segmentation Overview of the GMP Cell Therapy Consumables Market
The GMP cell therapy consumables market can be categorized into several key segments:

1) By Product Type:
- Kits
- Reagents or Molecular Biology Reagents
- Growth Factors or Cytokines and Interleukins
- Other Products

2) By Cell Therapy Type:
- NK Cell Therapy
- Stem Cell Therapy
- T-Cell Therapy

3) By Process Stage:
- Cell Collection and Characterization or Sorting and Separation
- Cell Culture and Expansion or Preparation
- Cryopreservation
- Cell Processing and Formulation
- Cell Isolation and Activation

4) By End-Use:
- Clinical
- Commercial

Further subcategories include:
- Kits such as Cell Culture Kits, Cell Isolation Kits, and Transfection Kits
- Molecular biology reagents including Buffers and Solutions, Enzymes, and Staining Reagents
- Growth factors and cytokines categorized into Hematopoietic Growth Factors and Immunomodulatory Cytokines
- Other consumables like Cell Culture Vessels, Media, and Supplements

This detailed segmentation provides a comprehensive framework for understanding the diverse product offerings and applications within the GMP cell therapy consumables market.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.